✦ LIBER ✦

Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patients

✍ Scribed by W.W. ten Bokkel Huinink; V. Lustig; R. Dubbelman; A. Hiemstra; S. Rodenhuis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced, refractory breast

✍ Werner Kwasny; Gabriela Kornek; Karin Haider; Julia Valencak; Herbert Ulrich-Pur 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 52 KB

Alternating and sequential administratio

✍ Jacek Jassem 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

0142 Feasibility study of fluorouracil/e

✍ Y. Rai; M. Tanaka; M. Mitsuyama; T. Uga; S. Tanaka; K. Nanba; H. Furusawa; K. Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase II multicentre randomised study of

✍ Bonneterre, J; Dieras, V; Tubiana-Hulin, M; Bougnoux, P; Bonneterre, M-E; Delozi 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

356 Persistent Pain, Sensory Disturbance

✍ K. Geving Andersen; M.B. Jensen; H. Kehlet; R. Gartner; L. Eckhoff; N. Kroman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase I study of docetaxel and cyclophos

✍ Tadao Shimizu; Kohji Enomoto; Shunsuke Haga; Mamoru Fukuda; Yuichi lino; Tadashi 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 776 KB